Search peptides, terms, sources/
Research source · 2026

Treatment With Mazdutide for Weight Reduction in Chinese Adults With Obesity: The GLORY-2 Randomized Clinical Trial

About this source

Kind
Research
Design
Human clinical trial, RCT
Population
462 randomised Chinese adults with obesity (BMI 30 or higher), with or without type 2 diabetes
Sample size
462
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 November 2026

Limitations

Chinese population only; mean age about 34. The Europe PMC record gives no funding statement, but several authors are affiliated with Innovent Biologics. Abstract read via Europe PMC; full text not read. The published title names the studied dose; it is left out here.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.